(CNN) — With a snip of a gene, doctors may one day permanently lower dangerously high cholesterol, possibly removing the need for medication, according to a new pilot study published Saturday in the New England Journal of Medicine .
The study was extremely small — only 15 patients with severe disease — and was meant to test the safety of a new medication delivered by CRISPR-Cas9, a biological sort of scissor which cuts a targeted gene to modify or turn it on or off.
Preliminary results, however, showed nearly a 50% reduction in low-density lipoprotein , or LDL, the “bad” cholesterol which plays a major role in heart disease — the No.1 killer of adults in the United States and worldwide .
The study, which will be presented Saturday at the American Heart Association Scientific

KTBS Health

Newsweek Top
Raw Story
Associated Press US and World News Video
New Hampshire Union Leader
People Human Interest
People Top Story
OK Magazine
The Conversation
ABC News